U.S. Airlines Stock News

Sigma Lithium Corporation reported past second-quarter 2026 results with sales of US$54.7 million versus US$16.89 million a year earlier, narrowing its net loss to US$2.64 million, while six‑month sales rose to US$97.04 million and net income reached US$8.49 million. Alongside beating production guidance with 35,000 tonnes of high‑grade lithium concentrate in the quarter, management outlined accelerated output targets and a planned restart of operations after talks with Minas Gerais...

In the second quarter of 2026, Keel Infrastructure Corp. reported sales of US$30.43 million, a net loss of US$65.00 million, and US$1.58 million in long-lived asset impairments, alongside a wider loss per share than the same period a year earlier. For the first half of 2026, sales fell to US$67.42 million while net loss increased to US$210.35 million, indicating pressure on both revenue and asset values as the company progresses its transition toward high performance computing and AI-focused...

S&P Global stock has dropped about 20.6% over the past year, yet the latest valuation checks paint a more balanced picture, with the intrinsic value estimate from the Excess Returns model sitting close to the current price while earnings based multiples lean on the expensive side. The share price is down 20.6% over the past year, which raises the question of whether recent weakness has already adjusted expectations or if it reflects pressure on the valuation. New index launches in private...

In the June quarter, United Airlines Holdings reported a 16% year-over-year revenue increase and an earnings beat despite elevated fuel costs, while billionaire Stanley Druckenmiller’s Duquesne Family Office lifted its stake in the airline by very large percentage to 794,795 shares. This combination of resilient profitability under cost pressure and increased backing from a high-profile institutional investor has sharpened attention on United’s underlying operating momentum and capital...

GRAIL announced that the FDA’s Molecular and Clinical Genetics Panel will meet on September 23, 2026, to review the Premarket Approval application for its Galleri multi-cancer early detection blood test, which targets cancer-specific methylation patterns and is intended to complement existing screening methods. This review marks a major regulatory inflection point for what GRAIL describes as the only multi-cancer early detection test backed by large interventional and randomized, controlled...

Visa (V) is back in the spotlight after Bill Ackman’s Pershing Square disclosed a new position, even as Berkshire Hathaway exited, while the company pushes deeper into stablecoin settlement and blockchain partnerships. See our latest analysis for Visa. Visa’s recent share price has eased slightly in the past week even after the Pershing Square stake disclosure and a series of announcements around stablecoin settlement. However, the 90 day share price return of 8.77% and 1 year total...

Event overview and why UniFirst matters now Uniform Bright has released a 161 page independent report on the proposed Cintas acquisition of UniFirst (UNF), focusing on competition, public contracts, regulatory timing, potential remedies, and the probability that the deal closes. This report gives UniFirst shareholders and merger arbitrage investors a detailed reference point for assessing deal terms, regulatory risk, and what assumptions might be reasonable for any post closing scenarios. See...

C.H. Robinson Worldwide (CHRW) reaffirmed its regular shareholder payout with a declared quarterly dividend of $0.63 per share, and it is also preparing to address investors at Deutsche Bank’s Chicago Industrials Summit on August 11, 2026. See our latest analysis for C.H. Robinson Worldwide. At a share price of US$144.78, C.H. Robinson Worldwide has seen its short term momentum fade, with the 1 month share price return down 30.56%. However, the 1 year total shareholder return of 19.60% and 5...

Targa Resources (TRGP) has drawn fresh attention after signing new long-term, fee-based agreements with ExxonMobil subsidiaries in the Permian Basin, backed by 20-year acreage and NGL dedications. See our latest analysis for Targa Resources. The ExxonMobil agreements land at a time when Targa Resources’ share price has risen strongly over 2026, with a year to date share price return of 48.81% and a 1 year total shareholder return of 76.29%, pointing to strong momentum built over several...

In August 2026, GE HealthCare introduced the LOGIQ e family, LOGIQ e Xi and LOGIQ e Si, compact, AI-enabled laptop ultrasound systems cleared in major markets and designed for fast, confident imaging across multiple clinical settings. The launch highlights GE HealthCare’s push into portable, AI-assisted point-of-care imaging, broadening its ultrasound portfolio and deepening digital integration in clinical workflows. Next, we’ll explore how this AI-powered, portable LOGIQ e launch fits into...

Natural Resource Partners L.P. recently reported its second-quarter 2026 results, with revenue of US$48.11 million and net income of US$24.67 million, and the board declared a cash distribution of US$0.75 per common unit for payment on August 25, 2026, to unitholders of record on August 18, 2026. The earnings release showed lower revenue and earnings per unit compared with the same period last year, even as the partnership continued to return cash to unitholders through its quarterly...

DorianG (LPG) is in focus after reporting first quarter 2026 earnings, with revenue of US$187.88 million and net income of US$138.29 million for the period ended June 30, 2026. See our latest analysis for DorianG. DorianG’s recent earnings release has landed against a backdrop of strong momentum, with a 30 day share price return of 18.01%, year to date share price return of 95.64% and a five year total shareholder return near 8x. This suggests investors are reassessing both growth potential...

In August 2026, Maximus, Inc. reported its fiscal third quarter results, showing quarterly revenue of US$1,278.97 million and net income of US$103.59 million, and updated full-year 2026 guidance to revenue of US$5.2–US$5.35 billion and net income of US$376–US$392 million with diluted EPS of US$6.94–US$7.24. Alongside these results, management reiterated its focus on disciplined acquisitions and share repurchases within a target net debt ratio of 2x–3x, emphasizing deals that expand...

Why Guardant Health Stock Is Back on Investors’ Radar Guardant Health (GH) moved into focus after several Q2 2026 developments, including FDA approval of an updated Guardant360 liquid biopsy test and new American Cancer Society support for its Shield colorectal cancer screening. These clinical and guideline milestones arrived alongside stronger than expected Q1 results related to test volume and coverage trends. This provided investors with fresh information on how the company’s product...

Turning Point Brands (TPB) has drawn fresh attention after raising its 2026 earnings guidance tied to Modern Oral products. The update comes alongside recent sales figures and the launch of FRE Labs flavor drops. See our latest analysis for Turning Point Brands. Despite the stronger Modern Oral outlook and the launch of FRE Labs, Turning Point Brands' share price has softened recently, with the stock down 22.62% year to date on a share price basis, while still showing a very large 3 year...

In August 2026, MP Materials reported second-quarter 2026 results showing rare earth oxide production of 11,072 MT, NdPr output of 840 MT, and sales of US$108.49 million, alongside a narrower net loss of US$20.3 million compared with the prior year. The simultaneous ramp-up in higher-value NdPr production and reduced losses suggests MP Materials is shifting its production mix toward more processed, magnet-ready rare earth materials. We’ll now examine how the stronger NdPr production and...

Universal Insurance Holdings (UVE) has been drawing fresh attention after recent trading, with the stock last closing at $42.69. Investors are weighing this price against the company’s recent returns and current profitability profile. See our latest analysis for Universal Insurance Holdings. Recent trading softness, reflected in the 1-day share price return of 1.20% and 7-day share price return of 1.66%, comes after a stronger run, with a 30-day share price return of 9.71% and year to date...

In early August 2026, ONE Gas, Inc. reported higher second-quarter and first-half net income despite lower sales, affirmed a US$0.68 quarterly dividend payable on August 31, 2026, and completed a US$375 million fixed-rate, callable senior notes offering due 2036 priced at 99.675% of par. Together with amended by-laws that expand the board chair’s committee role, these moves highlight ONE Gas’s focus on reinforcing governance, funding long-lived infrastructure, and sustaining its long-running...

Earnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, alongside updated revenue guidance for the second quarter and full fiscal year. See our latest analysis for Doximity. Doximity’s share price has climbed 27.31% over the past 90 days and 13.94% over the past month, yet remains down 43.36% year to date, while the 1 year total shareholder return is down 62.81%...

Arcos Dorados Holdings Inc. recently reported past half-year results to June 30, 2026, with revenue rising to US$2,521.6 million from US$2,218.89 million a year earlier and net income increasing to US$81.15 million from US$36.52 million, lifting basic earnings per share from continuing operations to US$0.39 from US$0.17. The combination of higher sales and more than doubled net income suggests the company converted stronger demand into improved profitability during the first half. Next,...

Neurocrine Biosciences (NBIX) has put INGREZZA back in focus after publishing KINECT-PRO Phase 4 results that link once-daily treatment with sustained improvements in tardive dyskinesia symptoms and patient-reported quality of life in real-world settings. See our latest analysis for Neurocrine Biosciences. The INGREZZA data arrives after a mixed trading patch for Neurocrine Biosciences, with the share price down 9.6% over 30 days but still showing a 9.9% year to date share price return and a...

East West Bancorp stock has returned 168.2% over the past 3 years, yet the latest valuation work suggests a more measured picture, with the Excess Returns intrinsic value estimate pointing to upside while traditional earnings multiples look roughly in line with the market. Over the last 3 years, a 168.2% share price gain places East West Bancorp among the stronger performers, which raises the question of how much of that strength is already reflected in today’s price. Future returns may...

Northwest Natural Holding Company recently reported past second-quarter 2026 results showing sales of US$243.55 million and a net income of US$0.6 million, reversing a net loss a year earlier, and modestly higher six-month sales and earnings. The company also indicated that 2026 EPS is now expected to land in the upper half of its US$2.95–US$3.15 guidance range, pointing to stronger operating momentum across its regulated and growth platforms. With management now guiding 2026 EPS toward...

Applied Materials reported third-quarter 2026 results with sales of US$9.12 billion and net income of US$2.54 billion, alongside raising its fourth-quarter revenue outlook to US$10.25 billion. Beyond the headline numbers, the company continued its multi-year share repurchase program and expanded its EPIC Center research collaboration with UC Berkeley to accelerate AI-focused semiconductor innovation. We’ll now examine how this combination of record quarterly performance and expanded UC...